Tibet Aim Pharm Inc (002826) — Strategic Asset Allocation Index
Tibet Aim Pharm Inc (002826) has a Strategic Asset Allocation Index of 46.5% as of September 2023. Strategic assets (PP&E of CN¥353.23 Million plus long-term investments of CN¥-) total CN¥353.23 Million, measured against net assets of CN¥758.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Tibet Aim Pharm Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tibet Aim Pharm Inc Strategic Asset Allocation Index (2013–2022)
This chart shows how Tibet Aim Pharm Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 46.5%, representing strategic assets of CN¥353.23 Million against net assets of CN¥758.99 Million CNY. For live market cap and overall valuation, see market value of Tibet Aim Pharm Inc.
Annual Strategic Asset Allocation Index for Tibet Aim Pharm Inc (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tibet Aim Pharm Inc from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Tibet Aim Pharm Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 48.6% | CN¥364.85 Million | CN¥364.85 Million | CN¥- | CN¥750.00 Million | ▼ -4.0 pp |
| 2021 | 52.6% | CN¥378.96 Million | CN¥378.96 Million | CN¥- | CN¥720.11 Million | ▼ -5.0 pp |
| 2020 | 57.7% | CN¥396.15 Million | CN¥396.15 Million | CN¥- | CN¥687.15 Million | ▲ +1.2 pp |
| 2019 | 56.4% | CN¥368.15 Million | CN¥368.15 Million | CN¥- | CN¥652.17 Million | ▲ +24.4 pp |
| 2018 | 32.1% | CN¥198.39 Million | CN¥198.39 Million | CN¥- | CN¥618.40 Million | ▲ +2.7 pp |
| 2017 | 29.3% | CN¥177.36 Million | CN¥177.36 Million | CN¥- | CN¥604.53 Million | ▲ +4.2 pp |
| 2016 | 25.2% | CN¥139.81 Million | CN¥139.81 Million | CN¥- | CN¥555.44 Million | ▼ -29.4 pp |
| 2015 | 54.6% | CN¥135.54 Million | CN¥135.40 Million | CN¥140.00K | CN¥248.25 Million | ▲ +29.3 pp |
| 2014 | 25.3% | CN¥45.37 Million | CN¥45.37 Million | CN¥- | CN¥179.12 Million | ▼ -11.3 pp |
| 2013 | 36.6% | CN¥26.24 Million | CN¥26.24 Million | CN¥- | CN¥71.66 Million | — |